0001209191-19-002244.txt : 20190104
0001209191-19-002244.hdr.sgml : 20190104
20190104182142
ACCESSION NUMBER: 0001209191-19-002244
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181224
FILED AS OF DATE: 20190104
DATE AS OF CHANGE: 20190104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DIGIANDOMENICO ANTHONY
CENTRAL INDEX KEY: 0001083544
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 19511558
MAIL ADDRESS:
STREET 1: 3600 GREEN COURT, SUITE 350
CITY: ANN ARBOR
STATE: MI
ZIP: 48105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 W. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 675 W. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-24
0
0001645460
Cue Biopharma, Inc.
CUE
0001083544
DIGIANDOMENICO ANTHONY
2425 CEDAR SPRINGS ROAD
DALLAS
TX
75201
1
0
0
0
Common Stock
2018-12-24
4
P
0
10000
4.81
A
30000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.51 to $4.94, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4
Shares are held jointly with the reporting person's spouse.
/s/ Anthony DiGiandomenico by Mark R. Busch, attorney-in-fact
2019-01-04